Profusa
PFSA
Profusa (PFSA) news
Recent news
Profusa announces Q2 2026 financial results and progress on the option agreement conditions to close with G3 Vision Labs, a commercial stage diagnostics company
AInvest Wire · Aug 20, 2026Profusa, Inc.: Profusa: signing of option pact for purchase of a commercial stage diagnostics co. G3 Vision Labs
AInvest Wire · Jul 31, 2026ProfUSA - enters option agreement to buy G3 Vision Labs and affiliates - SEC filing
ProfUSA Inc. (NASDAQ: PFSA) has entered into an asset purchase agreement with Bio Insights LLC to acquire substantially all of the know-how assets related to the PanOmics Assay, an integrated multi-omics analysis platform used in drug discovery and precision medicine. The transaction, announced on…
AInvest Wire · Jul 31, 2026ProfUSA - expects to close $7 mln financing via convertible note with 7% interest rate
AInvest Wire · Jul 27, 2026Profusa - to issue 19.99% common shares and convertible preferred stock to DX company stockholders
AInvest Wire · Jul 27, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.